A double-blind, randomized, placebo-controlled clinical trial on benfotiamine treatment in patients with diabetic nephropathy. [electronic resource]
Producer: 20101021Description: 1598-601 p. digitalISSN:- 1935-5548
- Adjuvants, Immunologic -- administration & dosage
- Adult
- Aged
- Albuminuria -- drug therapy
- Angiotensin II Type 1 Receptor Blockers -- therapeutic use
- Angiotensin-Converting Enzyme Inhibitors -- therapeutic use
- Biomarkers -- urine
- Diabetes Mellitus, Type 2 -- drug therapy
- Diabetic Nephropathies -- drug therapy
- Double-Blind Method
- Drug Therapy, Combination
- Female
- Hepatitis A Virus Cellular Receptor 1
- Humans
- Kidney Tubules -- drug effects
- Male
- Membrane Glycoproteins -- urine
- Middle Aged
- Placebos
- Receptors, Virus
- Thiamine -- administration & dosage
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.